| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.007 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |